Blaj S, Piso P. Which patient is going to benefit from surgical cytoreduction with intraperitoneal chemotherapy (for manifest peritoneal metastases)?. Curr. Issues Pharm. Med. Sci. [Internet]. 2018 Jan. 15 [cited 2025 Jul. 13];30(4):207-10. Available from: https://czasopisma.umlub.pl/curipms/article/view/686